Oscar Health, Inc.OSCREarnings & Financial Report
Oscar Health, Inc. is an American for-profit health insurance company, founded in 2012 by Joshua Kushner, Kevin Nazemi and Mario Schlosser, and is headquartered in New York City. The company focuses on the health insurance industry through telemedicine, healthcare focused technological interfaces, and transparent claims pricing systems which would make it easier for patients to navigate.
Revenue
$3.0B
Gross Profit
N/A
Operating Profit
$-129.3M
Net Profit
$-137.4M
Gross Margin
N/A
Operating Margin
-4.3%
Net Margin
-4.6%
YoY Growth
23.2%
EPS
$-0.53
Oscar Health, Inc. Q3 FY2025 Financial Summary
Oscar Health, Inc. reported revenue of $3.0B (up 23.2% YoY) for Q3 FY2025, with a net profit of $-137.4M (down 151.8% YoY) (-4.6% margin).
Key Financial Metrics
| Total Revenue | $3.0B |
|---|---|
| Net Profit | $-137.4M |
| Gross Margin | N/A |
| Operating Margin | -4.3% |
| Report Period | Q3 FY2025 |
Oscar Health, Inc. Annual Revenue by Year
Oscar Health, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $11.7B).
| Year | Annual Revenue |
|---|---|
| 2025 | $11.7B |
| 2024 | $9.2B |
| 2023 | $21.4M |
| 2022 | $64.9M |
Oscar Health, Inc. Quarterly Revenue & Net Profit History
Oscar Health, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $2.8B | +17.3% | $-352.6M | -3933.2% |
| Q3 FY2025 | $3.0B | +23.2% | $-137.4M | -4.6% |
| Q2 FY2025 | $2.9B | +29.0% | $-228.4M | -8.0% |
| Q1 FY2025 | $3.0B | +42.2% | $275.3M | 9.0% |
| Q4 FY2024 | $2.4B | +67.1% | $-153.5M | -3190.9% |
| Q3 FY2024 | $2.4B | +68.3% | $-54.6M | -2.3% |
| Q2 FY2024 | $2.2B | +45.9% | $56.2M | 2.5% |
| Q1 FY2024 | $2.1B | +45.8% | $177.4M | 8.3% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.14B | $2.22B | $2.42B | $2.39B | $3.05B | $2.86B | $2.99B | $2.81B |
| YoY Growth | 45.8% | 45.9% | 68.3% | 67.1% | 42.2% | 29.0% | 23.2% | 17.3% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $4.42B | $5.01B | $4.48B | $4.84B | $5.84B | $6.38B | $5.75B | $6.33B |
| Liabilities | $3.38B | $3.87B | $3.32B | $3.82B | $4.51B | $5.22B | $4.72B | $5.34B |
| Equity | $1.03B | $1.14B | $1.16B | $1.01B | $1.33B | $1.16B | $1.02B | $977.6M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $634.4M | $497.2M | $-500.1M | $978.2M | $878.5M | $509.1M | $-964.7M | $1.09B |